SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-16-569970
Filing Date
2016-04-29
Accepted
2016-04-29 17:10:41
Documents
9
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d153538d10ka.htm 10-K/A 906190
2 EX-4.1 d153538dex41.htm EX-4.1 33646
3 EX-10.15 d153538dex1015.htm EX-10.15 73092
4 EX-31.1 d153538dex311.htm EX-31.1 2567
5 EX-31.2 d153538dex312.htm EX-31.2 2764
6 GRAPHIC g153538017.jpg GRAPHIC 19102
7 GRAPHIC g153538018.jpg GRAPHIC 32415
8 GRAPHIC g153538ex4_1a.jpg GRAPHIC 180733
9 GRAPHIC g153538ex4_1bnew.jpg GRAPHIC 3270
  Complete submission text file 0001193125-16-569970.txt   1344156
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36172 | Film No.: 161608145
SIC: 2836 Biological Products, (No Diagnostic Substances)